SCHEMBL3849059

SCHEMBL3849059

COc1ccc(-c2ccc(-c3nn(C(c4ccccc4)(c4ccccc4)c4ccccc4)cc3Br)cc2)cn1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 7/20 0.42
HSD17B1 P14061 1/20 0.40
HSD17B2 P37059 1/20 0.40
GRM5 P41594 1/20 0.39
MKNK1 Q9BUB5 1/20 0.38
MKNK2 Q9HBH9 1/20 0.38
TEK Q02763 4/20 0.37
CYP2A6 P11509 1/20 0.36
EPHB4 P54760 3/20 0.36
CHEK1 O14757 1/20 0.36
OXTR P30559 1/20 0.35
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
JAK2 O60674 1/20 0.34
PDGFRB P09619 1/20 0.34
PDGFRA P16234 1/20 0.34
NPC1 O15118 1/20 0.34
LMNA P02545 1/20 0.34
PKM P14618 1/20 0.34
ATR Q13535 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3846335 0.95 KDR (0.38) KDRHSD17B1HSD17B2GRM5MKNK1
SCHEMBL3853768 0.84 HSD17B1 (0.41) KDRHSD17B1HSD17B2GRM5MKNK1
SCHEMBL3846485 0.83 RAB9A (0.45) MEN1KMT2ANPC1LMNA
SCHEMBL519563 0.79 KDM4E (0.36) MKNK2MEN1KMT2ANPC1PKM
SCHEMBL3848389 0.79 KDR (0.37) KDRHSD17B1HSD17B2GRM5MKNK1
SCHEMBL3848485 0.79 MEN1 (0.42) MEN1KMT2ANPC1
SCHEMBL3850830 0.77 L3MBTL1 (0.46) MEN1KMT2ANPC1LMNA
SCHEMBL3845928 0.77 KDR (0.46) KDRHSD17B1HSD17B2GRM5MKNK1
SCHEMBL3848071 0.77 ALDH1A1 (0.46) MEN1KMT2ANPC1
SCHEMBL3846787 0.76 POLB (0.39) KDRMEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed